Cambridge, MA · Founded 2019 · Privately Held (backing)
Developer of a biomedical neuromodulation therapy designed to sustain pain relief and support mobility. Brixton Biosciences is based in Cambridge, MA and was founded in 2019. It has raised $41 million.
Last price · $/share
—
Implied valuation
—
Total raised
$41.0M
Last round
—
Cap table — not yet on record
Brixton Biosciences's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Brixton Biosciences with a free account
·The complete investor list: 11 names
·Watch Brixton Biosciences: the Monday email on marks, rounds and moves
